Price $241.16 |
Market Cap
70.6B
|
Sector Health Care |
Div. Growth
4.50%
|
|
P/E
38.4
|
P/B
2.94
|
P/S
3.56
|
Dividend %
1.40%
|
|
P/CF
228.5
|
P/FCF
23.1
|
Op. Cash Flow
5.18M
|
FCF
10.6
|
|
Op. Margin
12.70%
|
Net Margin
9.40%
|
ROE
7.70%
|
ROI
3.30%
|
|
ROA
3.40%
|
EPS Growth
124.50%
|
Current Ratio
1.5
|
Debt/Equity
72.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| La Jolla Pharmaceutical Compan (LJPC) | $3.96 | - | - | 109.7M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.62 | - | - | 78.9M | Strong Buy |
| Lannett Company, Inc. (LCI) | $2.53 | - | - | 126.8M | Strong Buy |
| Psychemedics Corp. (PMD) | $8.36 | - | - | 46.6M | Strong Buy |
| Capital Senior Living Corporat (CSU) | $30.91 | - | - | 77.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
